Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Alaproclate")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 52

  • Page / 3
Export

Selection :

  • and

Role of serotonin in memory: facilitation by alaproclate and zimeldineALTMAN, H. J; NORDY, D. A; OGREN, S. O et al.Psychopharmacologia. 1984, Vol 84, Num 4, pp 496-502, issn 0033-3158Article

ON THE MOLECULAR STRUCTURE OF SOME PSYCHOACTIVE DRUGS: STUDIES OF THE ANTIDEPRESSANT ALAPROCLATE AND TWO POTENTIALLY NEUROLEPTIC RIGID SPIRO AMINESWAEGNER A.1980; CHEM. COMMUN. (STOCKH.); ISSN 0366-5607; SWE; DA. 1980; NO 5; PP. 1-61; BIBL. 8 P.Serial Issue

Alaproclate, a new selective 5-HT uptake inhibitor with therapeutic potential in depression and senile dementiaÖGREN, S.-O; HOLM, A.-C; HALL, H et al.Journal of neural transmission. 1984, Vol 59, Num 4, pp 265-288, issn 0300-9564Article

Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimeldineABERG-WISTEDT, A; ALVARIZA, M; BERTILSSON, L et al.Acta psychiatrica Scandinavica. 1985, Vol 71, Num 3, pp 256-268, issn 0001-690XArticle

Studies of some characteristics of molecular dissolution kinetics from rotating discsNICKLASSON, M; BRODIN, A; SUNDELOF, L.-O et al.International journal of pharmaceutics. 1985, Vol 23, Num 1, pp 97-108, issn 0378-5173Article

Correlations between in vitro dissolution rate and bioavaibility of alaproclate tabletsGRAFFNER, C; NICKLASSON, M; LINDGREN, J.-E et al.Journal of pharmacokinetics and biopharmaceutics. 1984, Vol 12, Num 4, pp 367-380, issn 0090-466XArticle

The effects of alaproclate on the pupillary responses to tyramine, phenylephrine and pilocarpine in depressed patientsTHOMPSON, C; CHECKLEY, S. A.Psychopharmacologia. 1985, Vol 85, Num 1, pp 65-68, issn 0033-3158Article

NMDA receptor-mediated increase in cyclic GMP in the rat cerebellum in vivo is blocked by alaproclate and GEA-857HU, P.-S; ROSS, S. B.Pharmacology & toxicology. 1997, Vol 80, Num 2, pp 97-102, issn 0901-9928Article

Potentiation of oxotremorine-induced hypothermia by alaproclate in PCA lesioned and non-lesioned ratsDILSAVER, S. C; NORMILE, H. J; ALTMAN, H. J et al.Psychopharmacologia. 1989, Vol 97, Num 1, pp 51-53, issn 0033-3158Article

TEST-SPECIFIC EFFECTS OF THE 5-HT REUPTAKE INHIBITORS ALAPROCLATE AND ZIMELIDINE ON PAIN SENSITIVITY AND MORPHINE ANALGESIAOEGREN SO; HOLM AC.1980; J. NEUR. TRANSM.; AUT; DA. 1980; VOL. 47; NO 4; PP. 253-271; BIBL. 3 P.Article

The effects of alaproclate and p-chlorophenylalanine on cued navigation performance in ratsJÄKÄLÄ, P; SIRVIÖ, J; RIEKKINEN, P. JR et al.Journal of neural transmission - Parkinson's disease and dementia section. 1992, Vol 4, Num 1, pp 43-52, issn 0936-3076Article

Influence of alaproclate on antipyrine metabolite formation in manTEUNISSEN, M. W. E; WAHLEN, A; VINNARS, E et al.European journal of clinical pharmacology. 1984, Vol 27, Num 4, pp 447-452, issn 0031-6970Article

The effects of zimeldine and alaproclate combined with a small dose of 5-HTP on waking and sleep stages in catsSOMMERFELT, L; URSIN, R.Behavioural brain research. 1987, Vol 24, Num 1, pp 1-10, issn 0166-4328Article

Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorderWAGNER, A; ABERG-WISTEDT, A; ASBERG, M et al.Archives of general psychiatry. 1987, Vol 44, Num 10, pp 870-877, issn 0003-990XArticle

A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementiaDEHLIN, O; HEDENRUD, B; JANSSON, P et al.Acta psychiatrica Scandinavica. 1985, Vol 71, Num 2, pp 190-196, issn 0001-690XArticle

Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouseOGREN, S. O; CARLSSON, S; BARTFAI, T et al.Psychopharmacologia. 1985, Vol 86, Num 3, pp 258-264, issn 0033-3158Article

Alaproclate: further pharmacological evidence for 5-HT uptake inhibition in vivoRAWLOW, A; PAWLOWSKI, L; PRZEGALINSKI, E et al.Archives internationales de pharmacodynamie et de thérapie. 1983, Vol 265, Num 2, pp 219-229, issn 0003-9780Article

Antidepressant binding to the porcine and human platelet serotonin transportersHUMPHREYS, C. J; LEVIN, J; RUDNICK, G et al.Molecular pharmacology. 1988, Vol 33, Num 6, pp 657-663, issn 0026-895XArticle

Investigation into the effects in-vivo of the 5-hydroxytryptamine reuptake inhibitor, alaproclate, on carbachol-stimulated inositol phospholipid breakdown in the rat cerebral cortexFOWLER, C. J; THORELL, G; OGREN, S.-O et al.Journal of pharmacy and pharmacology. 1987, Vol 39, Num 12, pp 1015-1018, issn 0022-3573Article

Application of stabase protection in the α-methylation of alaproclate, an alanine ester of a tertiary phenethyl alcoholHOGBERG, T; STROM, P; LINDBERG, U. H et al.Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry. 1985, Vol 39, Num 5, pp 414-416, issn 0302-4369Article

Effects of alaproclate and morphine on the ventilatory response to carbon dioxide in normal manCALVERLEY, P. M. A; CARMICHAEL, G. L. M; SCOTT, D. B et al.British Journal of Anaesthesia. 1983, Vol 55, Num 9, pp 843-847, issn 0007-0912Article

STUDIES ON THE PHYSICAL PROPERTIES OF TABLETS AND TABLET EXCIPIENTS. IV: A PROGRAM FOR ACCELERATED LIGHT STABILITY TESTINGNYQVIST H; NICKLASSON M; LUNDGREN P et al.1982; ACTA PHARM. SUEC.; ISSN 0001-6675; SWE; DA. 1982; VOL. 19; NO 2; PP. 91-98; BIBL. 11 REF.Article

Alaproclate increases the excitability of hippocampal CA1 pyramidal cells and blocks the slow after-hyperpolarizationHEDLUND, B; ANDERSEN, P.Pharmacology & toxicology. 1989, Vol 65, Num 3, pp 185-188, issn 0901-9928, 4 p.Article

Effects of acute systemic treatment with the 5 HT-uptake blocker alaproclate on tissue levels and release of substance P in rat periaqueductal greyROSEN, A; FRANCK, J; BRODIN, E et al.Neuropeptides (Edinburgh). 1995, Vol 28, Num 6, pp 317-324, issn 0143-4179Article

Comparison of desipramine amitriptyline, zimeldine and alaproclate in six animal models used to investigate antidepressant drugsDANYSZ, W; PLAZNIK, A; KOSTOWSKI, W et al.Pharmacology & toxicology. 1988, Vol 62, Num 1, pp 42-50, issn 0901-9928Article

  • Page / 3